Fentanyl returns
Executive Summary
Anesthetic is no longer in short supply, FDA reports, with manufacturers Taylor, Abbott and ESI Lederle now able to meet demands. Shortages of fentanyl and other anesthetic agents were the subject of a recent "alert" by the American Society of Anesthesiologists (1"The Pink Sheet" March 19, p. 16)
You may also be interested in...
Abbott Doubles Fentanyl Production To Address Hospital Shortages
Abbott has doubled the production of fentanyl to respond to supply shortages of the anesthetic in hospitals around the country, the company said.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials